What type of study is this?

This is a Quantitative Study study (also classified as: Animal Study).

Validation on the First-Tier Fully Automated High-Throughput SMN1, SMN2, TREC, and RPP30 Quantification by Quadruplex Droplet Digital PCR for Newborn Screening for Spinal Muscular Atrophy and Severe Combined Immunodeficiency

View Full Paper

Ask AI

Bookmark

Authors

First-tier quadruplex ddPCR quantifies SMN1, SMN2, and TREC in newborns, indicating reliable detection and early intervention.

The automated quadruplex ddPCR assay accurately quantifies SMN1 and SMN2 in newborns, providing crucial data for SMA treatment.
Precision of the ddPCR for SMN1 and SMN2 is less than 7% CV for ≥0 copies, ensuring reliability in newborn screening.
Sanger sequencing confirms all SMA cases with homozygous deletions while achieving precise TREC quantification crucial for SCID diagnosis.
This two-tiered diagnostic approach enhances screening accuracy for SMA and SCID, enabling timely treatment and parental guidance.

Mak et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

View Full Paper

Ask AI

Bookmark

Authors

First-tier quadruplex ddPCR quantifies SMN1, SMN2, and TREC in newborns, indicating reliable detection and early intervention.

The automated quadruplex ddPCR assay accurately quantifies SMN1 and SMN2 in newborns, providing crucial data for SMA treatment.
Precision of the ddPCR for SMN1 and SMN2 is less than 7% CV for ≥0 copies, ensuring reliability in newborn screening.
Sanger sequencing confirms all SMA cases with homozygous deletions while achieving precise TREC quantification crucial for SCID diagnosis.
This two-tiered diagnostic approach enhances screening accuracy for SMA and SCID, enabling timely treatment and parental guidance.

Mak et al. (2025) studied this question.

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

View Full Paper

Ask AI

Bookmark